Evalve Announces Enrollment Completion Of The EVEREST Randomized Study

October 3rd, 2008 by admin

Evalve, Inc., the cheater in the utilization of devices for the percutaneous bushel of cardiac valves, declared the termination of irregular entering in the Endovascular Valve Edge-to-Edge REpair STudy (EVEREST), which is evaluating the MitraClip(R) grouping as a non-surgical bushel choice for patients pain from mitral regurgitation (MR). MR is the most ordinary identify of hunch regulator amount in the United States, moving jillions of grouping worldwide.

Tags: , ,

Posted in Cardiology |

Related posts

Comments are closed.